Hematologic Malignancy
Classic Follicular Lymphoma
CI-CAN-00007486Explore in graph →
Hematologic26 active trials1 approved drugs
- NCIt
- C200669
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00007486Explore in graph →
Clinical trials
194 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (44)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01864889 | Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19(CART19) | unknown | N/A | 12 | Chinese PLA General HospitalOTHER | 1 | Jan 28, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Jan 28, 2016source: clinicaltrials